Before initiating GLP-1 receptor agonist therapy, clinicians should document baseline heart rate and review the patient's cardiovascular history, including any arrhythmias, heart failure, or symptoms such as palpitations
Treatment with N-acetylcysteine partially rescued the tumor-promoting effects driven by NRF2 in FN3K-deficient models, underscoring the importance of NRF2-mediated redox homeostasis [138,139,140]
Gaspari T, Welungoda I, Widdop RE, Simpson RW, Dear AE
Before starting any GLP-1 therapywhether compounded or brandedpatients should undergo comprehensive assessment including medical history, baseline metabolic labs, and cardiovascular screening
Include calcium-rich foods and vitamin D supplementation
Reduced Withdrawal Symptoms: GLP-1 therapy may help manage depressive and anxiety-like behaviors that often accompany nicotine withdrawal